市場調查報告書
商品編碼
1466333
泌尿系統器具市場:按產品、適應症、最終用戶和應用分類 - 全球預測 2024-2030Urology Devices Market by Product (Dialysis Devices, Laser Systems, Lithotripters), Indication (Benign Prostatic Hyperplasia, Kidney Diseases, Pelvic Organ Prolapse), End-User, Application - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年泌尿系統器械市場規模為406.9億美元,預計2024年將達到444.1億美元,2030年將達到755.5億美元,複合年成長率為9.24%。
泌尿系統器械是用於診斷、監測和治療泌尿器官系統相關疾病的專用醫療設備和儀器。這些設備包括各種旨在解決影響男性生殖系統(包括腎臟、輸尿管、膀胱、尿道和前列腺)的多種泌尿器官系統疾病的產品。此外,隨著醫療技術的進步,許多泌尿系統設備融入了微創功能,增加了患者的康復時間並改善了整體治療結果。多種因素正在推動全球泌尿系統設備市場的成長,例如人口老化、泌尿系統疾病盛行率增加、技術進步以及人們對各種泌尿系統治療方法的認知不斷提高。然而,泌尿系統裝置的高成本、產品召回的災難性發生以及與泌尿系統裝置相關的技術限制正在阻礙市場的成長。微創或非侵入性技術的興起以及客製化、攜帶性和智慧連接的趨勢將推動該領域的大量研究活動和創新,進一步推動市場成長並擴大我們正在創造的市場機會。
主要市場統計 | |
---|---|
基準年[2023] | 406.9億美元 |
預測年份 [2024] | 444.1億美元 |
預測年份 [2030] | 755.5億美元 |
複合年成長率(%) | 9.24% |
產品泌尿系統內視鏡的普及可見一斑。
透析機是醫療設備,用於在腎臟無法自然執行這些功能時從血液中去除多餘的水、溶質和毒素。此類別包括血液透析機機和腹膜透析設備。血液透析機機包括血液幫浦、透析器和相關監測系統,以確保治療期間患者的安全。腹膜透析使用導管和患者腹部的腹膜作為膜來交換血液中的液體和溶解物質。透析設備的創新著重於提高患者舒適度、縮短治療時間並最大限度地減少潛在併發症。泌尿系統雷射系統有多種應用,包括治療尿路上皮癌、腎結石和良性前列腺增生 (BPH)。這些系統為目標組織提供精確的雷射能量,同時最大限度地減少對周圍區域的損害。碾碎是一種用於非侵入性治療腎結石和膽結石的專用設備。衝擊波可用於將結石破碎成更小的碎片,使它們自然地通過或使用微創方法去除。這些設備透過提供手術取石的替代方案徹底改變了泌尿系統治療。機器人手術系統提供了超越人手能力的精確性、彈性和控制能力,徹底改變了泌尿系統手術。這些系統具有微創手術的優點,包括減少疼痛、減少失血和加速恢復時間。尿動力學系統是評估膀胱、括約肌和尿道功能的診斷設備。它測量尿流率、膀胱內壓和殘餘尿量等變量,以幫助診斷和治療尿失禁、前列腺增生和神經源性膀胱等疾病。泌尿系統耗材包括導尿管、支架、導管導引線、引流袋等。這些產品對於各種泌尿系統應用至關重要,包括導尿管放置、術後引流和輸尿管支架留置。泌尿系統內視鏡是泌尿道內各種診斷和治療手術的必備儀器,例如膀胱鏡檢查、輸尿管鏡檢查和經尿道前列腺切除術(TURP)。這些儀器具有剛性和彈性,可實現泌尿系統疾病的可視化和治療。
用於診斷和治療指定腎臟疾病的泌尿系統裝置的需求不斷增加
泌尿系統裝置如經尿道微波熱療 (TUMT) 裝置、雷射系統和經尿道切除術(TURP)套件用於治療良性前列腺增生 (BPH)。這些裝置透過去除或縮小導致阻塞和發炎的多餘前列腺組織來幫助緩解泌尿系統症狀。植入式前列腺尿道抬高裝置等微創治療越來越普及,因為它們可以有效改善尿流,同時最大限度地減少副作用。對於腎結石、腎癌等腎臟疾病,常用震波碾碎、輸尿管鏡、經皮腎鏡取石術(PCNL)等設備。碎石機有助於非侵入性地將腎結石分解成可接受的大小。醫生使用輸尿管鏡來觀察和清除尿路結石並進行切片檢查。對於較大或更複雜的結石,PCNL 裝置會透過背部的小切口直接從腎臟取出結石。骨盆器官脫垂是指因骨盆底支撐結構減弱而導致骨盆腔器官下降。子宮托是一種標準的泌尿系統裝置,用於非手術治療脫垂,為下降的器官提供結構支撐。手術網片和套件也用於重組手術,以恢復正常的骨盆解剖結構和功能。機器人輔助腹腔鏡系統、近距離放射治療設備和高強度聚焦超音波(HIFU) 設備用於前列腺癌治療。機器人系統有助於精確地進行前列腺切除手術,具有減少疼痛和加速恢復時間等潛在好處。軟性和硬性輸尿管鏡用於內視鏡去除腎結石,並用作主要治療方法,特別是當結石的尺寸妨礙自然通過時。此外,鈥雷射透過提供高效且微創的結石碾碎方法,徹底改變了結石管理。
最終用戶:泌尿系統裝置在醫院和診所的廣泛使用
透析中心是為腎衰竭患者提供維持生命治療的專業醫療設施。這些中心利用各種泌尿系統設備,旨在當腎臟無法充分執行此功能時過濾血液中的毒素和廢物。此環境所使用的設備包括血液透析機機、腹膜透析設備以及透析器和導管等相關消耗品。透析中心需要可靠、高品質的設備來確保治療的安全性和有效性。醫院和診所是泌尿系統設備的廣泛最終用戶,涵蓋許多醫療機構,從小型門診診所到大型三級醫院。這些機構的泌尿系統使用泌尿系統設備來診斷、治療和管理泌尿系統疾病,例如尿失禁、良性前列腺增生、腎結石和尿道感染。此領域使用的主要設備包括導管、內視鏡、碎石機和雷射系統。醫院和診所也使用尿液動力學測試設備、泌尿系統手術器械和尿道支架。這些設施優先考慮能夠提高患者照護品質、提高業務效率並降低感染風險的設備。
應用擴大採用泌尿系統裝置來診斷和監測泌尿系統疾病
泌尿系統裝置有助於診斷和監測影響泌尿道和男性生殖系統的各種泌尿系統疾病。泌尿系統診斷設備包括膀胱鏡、尿動力系統和超音波診斷設備。這些設備可以對膀胱等區域進行目視檢查,收集尿流和壓力資料,並對泌尿系統結構進行非侵入性成像。患者監護設備追蹤泌尿器官系統的重要功能,並隨著時間的推移準確評估個人的狀況。產生的資料可幫助醫療保健專業人員就患者護理做出明智的決策,從而實現準確的診斷和有效的治療計劃。泌尿系統疾病的治療由各種旨在滿足患者特定需求的設備所支援。這些範圍從用於微創手術的內視鏡到用於破碎腎結石的體外震波碾碎(ESWL)。導管、支架和泌尿系統雷射為尿路阻塞和前列腺手術提供微創解決方案。此外,機器人手術系統擴大用於進行精密泌尿系統手術,改善治療效果並縮短患者復原時間。
區域洞察
由於先進的醫療基礎設施、人們對泌尿系統疾病的認知不斷提高以及行業參與者的強大影響力,美洲在全球泌尿系統器械市場中佔據重要地位。由於泌尿系統疾病的流行、醫療費用的上漲和有利的報銷政策,該區域市場正在經歷顯著成長。此外,技術創新和微創手術的日益普及正在推動該地區的市場成長。在歐洲地區,老年人口的增加和先進醫療技術的引入正在支撐泌尿系統器械市場。此外,有利的政府措施的實施和重要市場參與者的存在也有助於市場成長。增加對研發活動的投資以及改善醫療設施正在推動歐洲泌尿系統設備市場的成長。在中東和非洲,醫療基礎設施的改善、可支配收入的增加以及政府醫療保健現代化措施正在促進市場成長。由於醫療基礎設施和支出不斷擴大,以及該地區各國對泌尿系統疾病的認知不斷提高,亞太地區被認為是泌尿系統設備成長最快的市場。此外,該地區龐大的患者群和不斷改善的經濟狀況預計將為市場成長提供有利的機會。
FPNV定位矩陣
FPNV定位矩陣對於評估泌尿系統器械市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對泌尿系統器材市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭力評估及資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.泌尿系統器械市場的市場規模與預測是多少?
2.泌尿系統器械市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些?
3.泌尿系統器械市場的技術趨勢和法規結構是什麼?
4.泌尿系統器械市場主要廠商的市場佔有率是多少?
5. 進入泌尿系統器械市場的合適型態和策略手段是什麼?
[180 Pages Report] The Urology Devices Market size was estimated at USD 40.69 billion in 2023 and expected to reach USD 44.41 billion in 2024, at a CAGR 9.24% to reach USD 75.55 billion by 2030.
Urology devices are specialized medical instruments and apparatus used in diagnosing, monitoring, and treating disorders associated with the urinary system. These devices encompass various products designed to tackle multiple urological conditions that affect the kidneys, ureters, bladder, urethra, and male reproductive organs, including the prostate. Moreover, with advancements in medical technology, many urology devices incorporate minimally invasive features, enhancing patient recovery times and improving overall outcomes. Various factors, including the rise in the aging population, an increased prevalence of urological disorders, technological advancements, and the growing awareness regarding the availability of various urological treatments, propel the global urology devices market growth. However, the high cost of urology devices, the distressing rate of product recalls, and the technical limitations associated with urology devices hamper the market growth. The rise of minimally invasive or non-invasive techniques and the trends of customizability, portability, and smart connectivity have encouraged considerable research activities and innovation in this domain, further propelling the market growth and creating a market opportunity in the forecasted period.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 40.69 billion |
Estimated Year [2024] | USD 44.41 billion |
Forecast Year [2030] | USD 75.55 billion |
CAGR (%) | 9.24% |
Product: Significant penetration of urology endoscopes
Dialysis devices are medical apparatus used to remove excess water, solutes, and toxins from the blood in individuals whose kidneys cannot perform these functions naturally. This category includes hemodialysis and peritoneal dialysis equipment. Hemodialysis devices include blood pumps, dialyzers, and related monitoring systems to ensure patient safety during treatment. Peritoneal dialysis relies on a catheter and uses the peritoneum of the abdomen in the patient as a membrane through which fluids and dissolved substances are exchanged from the blood. The innovation in dialysis devices focuses on enhancing patient comfort, reducing treatment time, and minimizing potential complications. Laser systems in urology serve diverse applications, including treating urothelial carcinomas, kidney stones, and benign prostatic hyperplasia (BPH). These systems deliver precise laser energy to target tissue with minimal damage to surrounding areas. Lithotripters are specialized devices used in non-invasive kidney stones and gallstone treatment. They employ shock waves to break down calculi into smaller pieces that can be excreted naturally or removed with less invasive techniques. These devices have revolutionized urological care by providing an alternative to the surgical removal of stones. Robotic surgical systems have transformed urologic surgery by providing enhanced precision, flexibility, and control beyond the capabilities of the human hand. These systems offer the benefits of minimally invasive surgery, including reduced pain, less blood loss, and quicker recovery times. Urodynamic systems are diagnostic devices used to assess the functioning of the bladder, sphincters, and urethra. They measure variables such as urine flow rate, bladder pressure, and residual urine volume to aid in the diagnosis and management of conditions such as urinary incontinence, BPH, and neurogenic bladder. Urology consumables include catheters, stents, guidewires, and drainage bags. These products are essential for various urological applications comprising urinary catheterization, postoperative drainage, and ureteral stenting. Urology endoscopes are vital instruments for various diagnostic and therapeutic procedures within the urinary tract, such as cystoscopies, ureteroscopies, and transurethral resections of the prostate (TURP). These devices are rigid and flexible, enabling the visualization and treatment of urological conditions.
Indication: Growing need of urology devices to diagnose and treat kidney diseases
In the management of benign prostatic hyperplasia (BPH), urology devices such as transurethral microwave thermotherapy (TUMT) machines, laser systems, and transurethral resection (TURP) kits are used. These devices help alleviate urinary symptoms by removing or reducing excess prostate tissue that causes obstruction and irritation. Minimally invasive treatments, including implantable prostatic urethral lift devices, have become more prevalent due to their effectiveness in improving urinary flow while minimizing side effects. For kidney diseases, including kidney stones and kidney cancer, devices such as shock wave lithotripters, ureteroscopy, and percutaneous nephrolithotomy (PCNL) equipment are commonly used. Lithotripters help in non-invasively breaking down kidney stones into smaller, passable pieces. Ureteroscopes enable physicians to view and remove stones or perform biopsies within the urinary tract. For larger or complex stones, PCNL devices facilitate directly eliminating stones from the kidney through a small incision in the back. Pelvic organ prolapse involves the descent of pelvic organs caused by the weakening of the pelvic floor's supporting structures. Pessaries are standard urology devices utilized for the non-surgical management of prolapse, providing structural support to displaced organs. In reconstructive surgeries, surgical meshes and kits are also used to restore normal pelvic anatomy and function. Prostate cancer treatment involves the use of robotic-assisted laparoscopic systems, brachytherapy devices, and high-intensity focused ultrasound (HIFU) equipment. Robotic systems facilitate precise surgical removal of the prostate gland with potential benefits, including reduced pain and quicker recovery times. Flexible and rigid ureterorenoscopes are used for the endoscopic removal of kidney stones and serve as a primary treatment, especially when the stone size precludes spontaneous passage. Additionally, holmium lasers have revolutionized stone management by providing a highly effective and minimally invasive means of stone fragmentation.
End-User: Extensive use of urology devices by the hospitals & clinics
Dialysis centers are specialized medical facilities that provide life-sustaining treatment for patients with renal failure. These centers utilize various urology equipment designed to filter toxins and waste from the blood when the kidneys cannot perform this function adequately. The devices in these settings include hemodialysis machines, peritoneal dialysis equipment, and associated consumables such as dialyzers and catheters. Dialysis centers require reliable, high-quality devices to ensure the safety and efficacy of their treatment. Hospitals and clinics represent a broad end-user category for urology devices, covering many healthcare settings, from small outpatient clinics to large tertiary care hospitals. Urology departments within these institutions use urology devices to diagnose, treat, and manage urological conditions such as urinary incontinence, benign prostatic hyperplasia, kidney stones, and urinary tract infections. Key devices used in this sector include catheters, endoscopes, lithotripters, and laser systems. Hospitals and clinics may also use urodynamic testing equipment, surgical instruments designed for urological procedures, and urinary stents. These institutions prioritize devices that enhance patient care quality, increase operational efficiency, and reduce the risk of infection.
Application: Proliferating adoption of urology devices for diagnosis & monitoring of urological conditions
Urology devices are instrumental in diagnosing and monitoring various urological conditions affecting the urinary tract and the male reproductive system. Diagnostic urology devices include cystoscopes, urodynamic systems, and ultrasound devices. These tools allow for the visual inspection of areas such as the bladder, the collection of urine flow and pressure data, and the non-invasive imaging of urological structures. Patient monitoring devices track vital urological functions, ensuring accurate assessments of an individual's condition over time. The data obtained assist healthcare professionals in making informed decisions regarding patient care, leading to precise diagnoses and effective treatment plans. The treatment of urological conditions is supported by a wide array of devices designed to address the specific needs of patients. These range from endoscopes used in minimally invasive surgeries to extracorporeal shock wave lithotripsy (ESWL) machines for breaking down kidney stones. Catheters, stents, and urological lasers provide less invasive solutions for urinary obstructions and prostate surgeries. Additionally, robotic surgical systems are increasingly used to perform precise urological surgeries with improved outcomes and shortened patient recovery times.
Regional Insights
The Americas holds a significant position in the global urology devices market, driven by advanced healthcare infrastructure, heightened awareness of urological conditions, and a strong presence of industry players. The regional market experiences significant growth due to the prevalence of urological diseases, increased healthcare expenditure, and favorable reimbursement policies. In addition, technological innovations and the increasing adoption of minimally invasive surgeries are bolstering the market growth in this region. In the European region, the urology devices market is supported by a growing geriatric population and the adoption of advanced healthcare technologies. Additionally, implementing favorable government initiatives and the presence of significant market players contribute to market growth. Increased investment in research and development activities and the improvement in healthcare facilities are facilitating the growth of the urology devices market in Europe. In the Middle East and Africa, factors including improving healthcare infrastructure, rising disposable income, and government initiatives to modernize healthcare contribute to market growth. The Asia-Pacific region is identified as a rapidly growing market for urology devices attributable to the expanding healthcare infrastructure and expenditure and increasing awareness of urological conditions in regional countries. Moreover, the region's large patient pool and improving economic conditions are expected to offer lucrative opportunities for market growth.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Urology Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Urology Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Urology Devices Market, highlighting leading vendors and their innovative profiles. These include Advanced MedTech Holdings Pte. Ltd., Advin Health Care, Allium Medical Solutions Ltd., Ambu A/S, Asahi Kasei Medical Co., Ltd., B. Braun SE, Baxter International Inc., Becton, Dickinson, and Company, BlueWind Medical, Ltd., Boston Scientific Corporation, Cardinal Health, Inc., Coloplast A/S, Cook Group Incorporated, Dialife SA, Dornier MedTech GmbH, Erbe Elektromedizin GmbH, Fresenius SE & Co. KGaA, GE HealthCare Technologies, Inc., Gynesonics, Inc., Hollister Incorporated, Intuitive Surgical, Inc., Johnson & Johnson Services, Inc., KARL STORZ SE & Co. KG, Laborie Medical Technologies, Inc., McKesson Medical-Surgical Inc., Medline Industries, LP, Medtronic PLC, Nipro Medical Corporation, Olympus Corporation, Precision Optics Corporation, Richard Wolf GmbH, Rockwell Medical Inc., Siemens Healthcare GmbH, SonoMotion, Stryker Corporation, Teleflex Incorporated, Terumo Corporation, and Virtuoso Surgical, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Urology Devices Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Urology Devices Market?
3. What are the technology trends and regulatory frameworks in the Urology Devices Market?
4. What is the market share of the leading vendors in the Urology Devices Market?
5. Which modes and strategic moves are suitable for entering the Urology Devices Market?